Antimicrobial prescribing in nursing homes in Finland: Results of three point prevalence surveys

Infection

Volumn 41, Issue 2, 2013, Pages 355-360

  Rummukainen, M L ^a,b   Karki T ^b   Kanerva, M ^b,c   Haapasaari, M ^d   Ollgren, J ^b   Lyytikainen O ^b  

^a Central Finland Health Care District   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Turku Municipal Hospital   (Finland)

Author keywords

Antimicrobial; Nursing home; Point prevalence survey; Prophylaxis; Risk factor; Treatment

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN; METHENAMINE; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIVMECILLINAM; PSEUDOMONIC ACID; TRIMETHOPRIM; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; FEMALE; FINLAND; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PRESCRIPTION; PREVALENCE; URINARY TRACT INFECTION;

AGED, 80 AND OVER; AMDINOCILLIN PIVOXIL; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CONFIDENCE INTERVALS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; FINLAND; HOMES FOR THE AGED; HUMANS; MALE; METHENAMINE; NURSING HOMES; PREVALENCE; QUESTIONNAIRES; TRIMETHOPRIM; URINARY TRACT INFECTIONS;

EID: 84879499003     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0331-9     Document Type: Article

References (26)

1. Strausbaugh LJ. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis. 2001;7:268-71.
2. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:1722-30.
3. McClean P, Hughes C, Tunney M, Goossens H, Jans B; European Surveillance of Antimicrobial Consumption (ESAC) Nursing Home Project Group. Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother. 2011;66:1609-16.
4. Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011;66:2856-63.
5. Zimmer JG, Bentley DW, Valenti WM, Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J Am Geriatr Soc. 1986;34:703-10.
6. Jones SR, Parker DF, Liebow ES, Kimbrough RC 3rd, Frear RS. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med. 1987;83:499-502.
7. Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991;39:963-72.
8. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. J Hosp Infect. 2004;57:316-20.
9. Blix HS, Bergman J, Schjøtt J. How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiol Drug Saf. 2010;19:1025-30.
10. McClean P, Tunney M, Gilpin D, Parsons C, Hughes C. Antimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys. Drugs Aging. 2011;28:819-29.
11. Rummukainen ML, Jakobsson A, Matsinen M, Järvenpää S, Nissinen A, Karppi P, Lyytikäinen O. Reduction in inappropriate prevention of urinary tract infections in long-term care facilities. Am J Infect Control. 2012. doi: 10.1016/j.ajic.2011.09.013.
12. Larsen K, Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol. 2005;161:81-8.
13. Larsen K, Petersen JH, Budtz-Jørgensen E, Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics. 2000;56:909-14.
14. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60:290-7. doi: 10.1136/jech.2004.029454.
15. Lee BSB, Simpson JM, Craig JC, Bhuta T. Methenamine hippurate for preventing urinary tract infections. The Cochrane Library. 2010.
16. Puhto T, Ylipalosaari P, Ohtonen P, Syrjälä H. Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards. Infection. 2011;39:217-23.
17. Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;(3)CD001209.
18. Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother. 2000;46:35-9.
19. Holmberg L, Boman G, Böttiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med. 1980;69:733-8.
20. Pettersson E, Vernby Å, Mölstad S, Stålsby-Lundborg C. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis. 2008;40:393-8.
21. McNulty C, Freeman E, Smith G, Gunn K, Foy C, Tompkins D, et al. Prevalence of urinary catheterization in UK nursing homes. J Hosp Infect. 2003;55:119-23.
22. Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol. 2001;22:316-21.
23. Lyder CH. Pressure ulcer prevention and management. JAMA. 2003;289:223-6.
24. Park-Lee E, Caffrey C. Pressure ulcers among nursing home residents: United States, 2004. NCHS Data Brief. 2009;14:1-8.
25. Marchi M, Grilli E, Mongardi M, Bedosti C, Nobilio L, Moro ML. Prevalence of infections in long-term care facilities: how to read it? Infection. 2012. doi: 10.1007/s15010-012-0266-1.
26. Institutional Care and Housing Services in Social Care. Official Statistics of Finland National Institute for Health and Welfare. 2010.